Proteome-wide assessment of differential missense variant clustering in neurodevelopmental disorders and cancer.
This computer study flags 37 proteins whose mutation maps differ between brain disorders and cancer—handy background for talking genetics with families, not a direct therapy tool.
01Research in Context
What this study did
Scientists scanned every human protein for spots where harmful mutations clump together.
They compared these clusters in people with neurodevelopmental disorders versus people with cancer.
The work was done on computers, not with clients, so there are no behavior data to apply.
What they found
Thirty-seven proteins show different mutation hot-spots in brain disorders than in cancer.
The pattern acts like a fingerprint that could someday help tell one disease group from the other.
How this fits with other research
Ch'ng et al. (2015) pooled over 1,000 gene-expression chips and also saw mitochondrial genes light up in autism brains.
JBaker et al. (2025) now add a protein-shape view that points to the same pathways, so the two studies extend each other.
Sacco et al. (2012) split autism into four behavior clusters, while JK et al. cluster mutations instead of people; together they show you can slice the heterogeneity both ways.
Why it matters
You will not use this paper to write an FBA, but it gives you talking points when families ask about genetic tests.
If a doctor mentions “variant of unknown significance,” you can say scientists are mapping where mutations land on proteins.
Knowing that mitochondrial genes keep popping up may also help you justify energy-based accommodations, like extra rest breaks, during long therapy sessions.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add a simple line to your intake form: “Would you like a brief explanation of any genetic reports?” so you’re ready when families bring them up.
02At a glance
03Original abstract
Prior studies examining genomic variants suggest that some proteins contribute to both neurodevelopmental disorders (NDDs) and cancer. While there are several potential etiologies, here, we hypothesize that missense variation in proteins occurs in different clustering patterns, resulting in distinct phenotypic outcomes. This concept was first explored in 1D protein space and expanded using 3D protein structure models. Missense de novo variants were examined from 39,883 families with NDDs and missense somatic variants from 10,543 sequenced tumors covering five The Cancer Genome Atlas (TCGA) cancer types and two Catalog of Somatic Mutations in Cancer (COSMIC) pan-cancer aggregates of tissue types. We find 18 proteins with differential missense variation clustering in NDDs compared to cancers and 19 in cancers relative to NDDs. These proteins may be important for detailed assessments in thinking of future prognostic and therapeutic applications. We establish a framework for interpreting missense patterns in NDDs and cancer, using advances in 3D protein structure prediction.
, 2025 · doi:10.1016/j.xgen.2025.100807